The National Centre for Pharmacoeconomics (NCPE) in Ireland are undertaking an assessment of Lutathera for approval in Ireland which is the first step to getting PRRT (Peptide receptor radionuclide therapy) here in Ireland.
[more information on PRRT below]
This is very important for Irish NET Patients, as having PRRT available in Ireland would mean Patients do not have to travel to another country to get it.
This survey was part of the NET Patient Day events on Saturday, but we want everyone included, so here is the link for anyone that has not already done the survey.
I made it so that it takes under 2 minutes to complete, so I hope you can please take the time to do it.
Thanks
More info on PRRT
https://www.cancercenter.com/treatment-options/precision-medicine/targeted-therapy/peptide-receptor-radionuclide-therapy
Related posts
Read more about events, news and relevant NETs information
- A patient’s story about the help that Tommie Gorman gave her when she was newly diagnosed.A patient called Aimee Mc Clenahan from Sligo, did a outstanding radio interview about the help that Tommie gave her when she was newly diagnosed. Listen … Read more
- Tommie Gorman, R.I.P.We are all saddened by the sudden death of our Founder and President, Tommie Gorman. The idea of a patient support and advocacy group for Irish … Read more
- Volunteers for NET Patient Day 2024Volunteers were introduced for the first time at our Patient Day in Cork last November last year. We would like to thank them for supporting attendees … Read more
